These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34275907)

  • 1. Statins in Parkinson's Disease: Influence on Motor Progression.
    Palermo G; Giannoni S; Giuntini M; Belli E; Frosini D; Siciliano G; Ceravolo R
    J Parkinsons Dis; 2021; 11(4):1651-1662. PubMed ID: 34275907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's Disease Progression and Statins: Hydrophobicity Matters.
    Lewis MM; Albertson RM; Du G; Kong L; Foy A; Huang X
    J Parkinsons Dis; 2022; 12(3):821-830. PubMed ID: 34958045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts.
    Swallow DM; Lawton MA; Grosset KA; Malek N; Klein J; Baig F; Ruffmann C; Bajaj NP; Barker RA; Ben-Shlomo Y; Burn DJ; Foltynie T; Morris HR; Williams N; Wood NW; Hu MT; Grosset DG
    J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1183-1190. PubMed ID: 27671901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining the role of statins in Parkinson's disease risk reduction and disease modification: A comprehensive meta-analysis of 4 million participants' data.
    Mady A; Nabil Y; Daoud A; Alnajjar AZ; Alsalloum T; Marwan M; Abdelmeseh M; Elsayed M; Krayim A; Alaa M; Masoud M; Bushara N; Faisal R; Ahmed H; Saad M; Belabaci Z; Barrett MJ; Berman B; Negida A
    CNS Neurosci Ther; 2024 Aug; 30(8):e14888. PubMed ID: 39097909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of statins on dopamine loss and prognosis in Parkinson's disease.
    Jeong SH; Lee HS; Chung SJ; Yoo HS; Jung JH; Baik K; Lee YH; Sohn YH; Lee PH
    Brain; 2021 Nov; 144(10):3191-3200. PubMed ID: 34347020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin Use and Incidence of Parkinson's Disease in Women from the French E3N Cohort Study.
    Nguyen TTH; Fournier A; Courtois É; Artaud F; Escolano S; Tubert-Bitter P; Boutron-Ruault MC; Degaey I; Roze E; Canonico M; Ahmed I; Thiébaut ACM; Elbaz A
    Mov Disord; 2023 May; 38(5):854-865. PubMed ID: 36788159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Possible Role for HMG-CoA Reductase Inhibitors and Its Association with
    Pierzchlińska A; Droździk M; Białecka M
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the relationship between non-motor symptoms and health-related quality of life in Parkinson's disease: a retrospective observational cohort study.
    Ueno T; Kon T; Haga R; Nishijima H; Arai A; Tomiyama M
    Neurol Sci; 2020 Oct; 41(10):2867-2873. PubMed ID: 32328832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin use and risk of Parkinson's disease: A meta-analysis.
    Sheng Z; Jia X; Kang M
    Behav Brain Res; 2016 Aug; 309():29-34. PubMed ID: 27131781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of cholesterol level with dopamine loss and motor deficits in Parkinson disease: A cross-sectional study.
    Jeong SH; Lee HS; Chung SJ; Yoo HS; Jung JH; Baik K; Baik JS; Sohn YH; Lee PH
    Eur J Neurol; 2023 Jan; 30(1):107-115. PubMed ID: 36209467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.
    Regnault A; Boroojerdi B; Meunier J; Bani M; Morel T; Cano S
    J Neurol; 2019 Aug; 266(8):1927-1936. PubMed ID: 31073716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin usage, vascular diagnosis and vascular risk factors in Parkinson's disease.
    Cheng KK; Swallow DM; Grosset KA; Grosset DG
    Scott Med J; 2017 Aug; 62(3):104-109. PubMed ID: 28836927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study.
    Huang X; Alonso A; Guo X; Umbach DM; Lichtenstein ML; Ballantyne CM; Mailman RB; Mosley TH; Chen H
    Mov Disord; 2015 Apr; 30(4):552-9. PubMed ID: 25639598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between lipid levels and the risk of Parkinson's disease in individuals with diabetes mellitus: A nationwide population-based cohort study.
    Lee HJ; Han K; Kim YW; Yang SN; Yoon SY
    Parkinsonism Relat Disord; 2023 Dec; 117():105881. PubMed ID: 37951145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin use and Parkinson's disease in Denmark.
    Ritz B; Manthripragada AD; Qian L; Schernhammer E; Wermuth L; Olsen J; Friis S
    Mov Disord; 2010 Jul; 25(9):1210-6. PubMed ID: 20629142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins, cholesterol, Co-enzyme Q10, and Parkinson's disease.
    Lieberman A; Lyons K; Levine J; Myerburg R
    Parkinsonism Relat Disord; 2005 Mar; 11(2):81-4. PubMed ID: 15734664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa).
    Mollenhauer B; Zimmermann J; Sixel-Döring F; Focke NK; Wicke T; Ebentheuer J; Schaumburg M; Lang E; Friede T; Trenkwalder C;
    Mov Disord; 2019 Jan; 34(1):67-77. PubMed ID: 30468694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discontinuation of statin therapy associates with Parkinson disease: a population-based study.
    Lee YC; Lin CH; Wu RM; Lin MS; Lin JW; Chang CH; Lai MS
    Neurology; 2013 Jul; 81(5):410-6. PubMed ID: 23884037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin Use and Its Association with Essential Tremor and Parkinson's Disease.
    Shalaby SY; Louis ED
    Neuroepidemiology; 2016; 47(1):11-7. PubMed ID: 27304858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Segmental progression of early untreated Parkinson's disease: a novel approach to clinical rating.
    Schüpbach WM; Corvol JC; Czernecki V; Djebara MB; Golmard JL; Agid Y; Hartmann A
    J Neurol Neurosurg Psychiatry; 2010 Jan; 81(1):20-5. PubMed ID: 19622523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.